世界の糖尿病性ニューロパチー治療（DN）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Diabetic Neuropathy Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1836
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、92ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、糖尿病性ニューロパチー治療（DN）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（末梢神経障害、自律神経障害、近位神経障害、限局性神経障害）、用途別市場規模（病院、クリニック、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・糖尿病性ニューロパチー治療（DN）の市場動向
・企業の競争状況、市場シェア
・糖尿病性ニューロパチー治療（DN）の種類別市場規模（末梢神経障害、自律神経障害、近位神経障害、限局性神経障害）
・糖尿病性ニューロパチー治療（DN）の用途別市場規模（病院、クリニック、薬局）
・糖尿病性ニューロパチー治療（DN）の北米市場規模2016-2027（アメリカ、カナダ）
・糖尿病性ニューロパチー治療（DN）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・糖尿病性ニューロパチー治療（DN）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・糖尿病性ニューロパチー治療（DN）の中南米市場規模2016-2027（メキシコ、ブラジル）
・糖尿病性ニューロパチー治療（DN）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Abbott、Roche、Eli Lilly、Johnson & Johnson、GlaxoSmithKline、Lupin、Glenmark、Depomed、Astellas、Pfizer）
・結論

Diabetic neuropathy is a nerve damaging disorder associated with diabetes mellitus. Patients suffering from diabetes since a long time are prone to nerve damages throughout the body, as the symptoms of diabetic neuropathies cannot be diagnosed at an earlier stage.
Although there is no cure for diabetic neuropathy, it can be suppressed or prevented using various treatment modalities.

Market Analysis and Insights: Global Diabetic Neuropathy Treatment Market
The global Diabetic Neuropathy Treatment market size is projected to reach US$ 6036.6 million by 2026, from US$ 4544.9 million in 2019, at a CAGR of 4.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetic Neuropathy Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetic Neuropathy Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetic Neuropathy Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetic Neuropathy Treatment market.

Global Diabetic Neuropathy Treatment Scope and Market Size
Diabetic Neuropathy Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diabetic Neuropathy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Peripheral Neuropathy
Autonomic Neuropathy
Proximal Neuropathy
Focal Neuropathy

Segment by Application
Hospitals
Clinics
Pharmacy

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Roche
Eli Lilly
Johnson & Johnson
GlaxoSmithKline
Lupin
Glenmark
Depomed
Astellas

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetic Neuropathy Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Peripheral Neuropathy
1.2.3 Autonomic Neuropathy
1.2.4 Proximal Neuropathy
1.2.5 Focal Neuropathy
1.3 Market by Application
1.3.1 Global Diabetic Neuropathy Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Pharmacy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Diabetic Neuropathy Treatment Market Perspective (2016-2027)
2.2 Diabetic Neuropathy Treatment Growth Trends by Regions
2.2.1 Diabetic Neuropathy Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diabetic Neuropathy Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Diabetic Neuropathy Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Diabetic Neuropathy Treatment Industry Dynamic
2.3.1 Diabetic Neuropathy Treatment Market Trends
2.3.2 Diabetic Neuropathy Treatment Market Drivers
2.3.3 Diabetic Neuropathy Treatment Market Challenges
2.3.4 Diabetic Neuropathy Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Diabetic Neuropathy Treatment Players by Revenue
3.1.1 Global Top Diabetic Neuropathy Treatment Players by Revenue (2016-2021)
3.1.2 Global Diabetic Neuropathy Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Diabetic Neuropathy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diabetic Neuropathy Treatment Revenue
3.4 Global Diabetic Neuropathy Treatment Market Concentration Ratio
3.4.1 Global Diabetic Neuropathy Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetic Neuropathy Treatment Revenue in 2020
3.5 Diabetic Neuropathy Treatment Key Players Head office and Area Served
3.6 Key Players Diabetic Neuropathy Treatment Product Solution and Service
3.7 Date of Enter into Diabetic Neuropathy Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Diabetic Neuropathy Treatment Breakdown Data by Type
4.1 Global Diabetic Neuropathy Treatment Historic Market Size by Type (2016-2021)
4.2 Global Diabetic Neuropathy Treatment Forecasted Market Size by Type (2022-2027)

5 Diabetic Neuropathy Treatment Breakdown Data by Application
5.1 Global Diabetic Neuropathy Treatment Historic Market Size by Application (2016-2021)
5.2 Global Diabetic Neuropathy Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Diabetic Neuropathy Treatment Market Size (2016-2027)
6.2 North America Diabetic Neuropathy Treatment Market Size by Type
6.2.1 North America Diabetic Neuropathy Treatment Market Size by Type (2016-2021)
6.2.2 North America Diabetic Neuropathy Treatment Market Size by Type (2022-2027)
6.2.3 North America Diabetic Neuropathy Treatment Market Size by Type (2016-2027)
6.3 North America Diabetic Neuropathy Treatment Market Size by Application
6.3.1 North America Diabetic Neuropathy Treatment Market Size by Application (2016-2021)
6.3.2 North America Diabetic Neuropathy Treatment Market Size by Application (2022-2027)
6.3.3 North America Diabetic Neuropathy Treatment Market Size by Application (2016-2027)
6.4 North America Diabetic Neuropathy Treatment Market Size by Country
6.4.1 North America Diabetic Neuropathy Treatment Market Size by Country (2016-2021)
6.4.2 North America Diabetic Neuropathy Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Diabetic Neuropathy Treatment Market Size (2016-2027)
7.2 Europe Diabetic Neuropathy Treatment Market Size by Type
7.2.1 Europe Diabetic Neuropathy Treatment Market Size by Type (2016-2021)
7.2.2 Europe Diabetic Neuropathy Treatment Market Size by Type (2022-2027)
7.2.3 Europe Diabetic Neuropathy Treatment Market Size by Type (2016-2027)
7.3 Europe Diabetic Neuropathy Treatment Market Size by Application
7.3.1 Europe Diabetic Neuropathy Treatment Market Size by Application (2016-2021)
7.3.2 Europe Diabetic Neuropathy Treatment Market Size by Application (2022-2027)
7.3.3 Europe Diabetic Neuropathy Treatment Market Size by Application (2016-2027)
7.4 Europe Diabetic Neuropathy Treatment Market Size by Country
7.4.1 Europe Diabetic Neuropathy Treatment Market Size by Country (2016-2021)
7.4.2 Europe Diabetic Neuropathy Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Diabetic Neuropathy Treatment Market Size (2016-2027)
8.2 Asia-Pacific Diabetic Neuropathy Treatment Market Size by Type
8.2.1 Asia-Pacific Diabetic Neuropathy Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diabetic Neuropathy Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diabetic Neuropathy Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Diabetic Neuropathy Treatment Market Size by Application
8.3.1 Asia-Pacific Diabetic Neuropathy Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Diabetic Neuropathy Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Diabetic Neuropathy Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Diabetic Neuropathy Treatment Market Size by Region
8.4.1 Asia-Pacific Diabetic Neuropathy Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diabetic Neuropathy Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Diabetic Neuropathy Treatment Market Size (2016-2027)
9.2 Latin America Diabetic Neuropathy Treatment Market Size by Type
9.2.1 Latin America Diabetic Neuropathy Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Diabetic Neuropathy Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Diabetic Neuropathy Treatment Market Size by Type (2016-2027)
9.3 Latin America Diabetic Neuropathy Treatment Market Size by Application
9.3.1 Latin America Diabetic Neuropathy Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Diabetic Neuropathy Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Diabetic Neuropathy Treatment Market Size by Application (2016-2027)
9.4 Latin America Diabetic Neuropathy Treatment Market Size by Country
9.4.1 Latin America Diabetic Neuropathy Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Diabetic Neuropathy Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Diabetic Neuropathy Treatment Market Size (2016-2027)
10.2 Middle East & Africa Diabetic Neuropathy Treatment Market Size by Type
10.2.1 Middle East & Africa Diabetic Neuropathy Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diabetic Neuropathy Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diabetic Neuropathy Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Diabetic Neuropathy Treatment Market Size by Application
10.3.1 Middle East & Africa Diabetic Neuropathy Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Diabetic Neuropathy Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Diabetic Neuropathy Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Diabetic Neuropathy Treatment Market Size by Country
10.4.1 Middle East & Africa Diabetic Neuropathy Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diabetic Neuropathy Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Diabetic Neuropathy Treatment Introduction
11.1.4 Abbott Revenue in Diabetic Neuropathy Treatment Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Diabetic Neuropathy Treatment Introduction
11.2.4 Roche Revenue in Diabetic Neuropathy Treatment Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Diabetic Neuropathy Treatment Introduction
11.3.4 Eli Lilly Revenue in Diabetic Neuropathy Treatment Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Diabetic Neuropathy Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Diabetic Neuropathy Treatment Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Diabetic Neuropathy Treatment Introduction
11.5.4 GlaxoSmithKline Revenue in Diabetic Neuropathy Treatment Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Lupin
11.6.1 Lupin Company Details
11.6.2 Lupin Business Overview
11.6.3 Lupin Diabetic Neuropathy Treatment Introduction
11.6.4 Lupin Revenue in Diabetic Neuropathy Treatment Business (2016-2021)
11.6.5 Lupin Recent Development
11.7 Glenmark
11.7.1 Glenmark Company Details
11.7.2 Glenmark Business Overview
11.7.3 Glenmark Diabetic Neuropathy Treatment Introduction
11.7.4 Glenmark Revenue in Diabetic Neuropathy Treatment Business (2016-2021)
11.7.5 Glenmark Recent Development
11.8 Depomed
11.8.1 Depomed Company Details
11.8.2 Depomed Business Overview
11.8.3 Depomed Diabetic Neuropathy Treatment Introduction
11.8.4 Depomed Revenue in Diabetic Neuropathy Treatment Business (2016-2021)
11.8.5 Depomed Recent Development
11.9 Astellas
11.9.1 Astellas Company Details
11.9.2 Astellas Business Overview
11.9.3 Astellas Diabetic Neuropathy Treatment Introduction
11.9.4 Astellas Revenue in Diabetic Neuropathy Treatment Business (2016-2021)
11.9.5 Astellas Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Diabetic Neuropathy Treatment Introduction
11.10.4 Pfizer Revenue in Diabetic Neuropathy Treatment Business (2016-2021)
11.10.5 Pfizer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Diabetic Neuropathy Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Peripheral Neuropathy
Table 3. Key Players of Autonomic Neuropathy
Table 4. Key Players of Proximal Neuropathy
Table 5. Key Players of Focal Neuropathy
Table 6. Global Diabetic Neuropathy Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Diabetic Neuropathy Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Diabetic Neuropathy Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Diabetic Neuropathy Treatment Market Share by Regions (2016-2021)
Table 10. Global Diabetic Neuropathy Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Diabetic Neuropathy Treatment Market Share by Regions (2022-2027)
Table 12. Diabetic Neuropathy Treatment Market Trends
Table 13. Diabetic Neuropathy Treatment Market Drivers
Table 14. Diabetic Neuropathy Treatment Market Challenges
Table 15. Diabetic Neuropathy Treatment Market Restraints
Table 16. Global Diabetic Neuropathy Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Diabetic Neuropathy Treatment Market Share by Players (2016-2021)
Table 18. Global Top Diabetic Neuropathy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Neuropathy Treatment as of 2020)
Table 19. Ranking of Global Top Diabetic Neuropathy Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Diabetic Neuropathy Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Diabetic Neuropathy Treatment Product Solution and Service
Table 23. Date of Enter into Diabetic Neuropathy Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Diabetic Neuropathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Diabetic Neuropathy Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Diabetic Neuropathy Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Diabetic Neuropathy Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Diabetic Neuropathy Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Diabetic Neuropathy Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Diabetic Neuropathy Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Diabetic Neuropathy Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Diabetic Neuropathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Diabetic Neuropathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Diabetic Neuropathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Diabetic Neuropathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Diabetic Neuropathy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Diabetic Neuropathy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Diabetic Neuropathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Diabetic Neuropathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Diabetic Neuropathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Diabetic Neuropathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Diabetic Neuropathy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Diabetic Neuropathy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Diabetic Neuropathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Diabetic Neuropathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Diabetic Neuropathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Diabetic Neuropathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Diabetic Neuropathy Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Diabetic Neuropathy Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Diabetic Neuropathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Diabetic Neuropathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Diabetic Neuropathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Diabetic Neuropathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Diabetic Neuropathy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Diabetic Neuropathy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Diabetic Neuropathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Diabetic Neuropathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Diabetic Neuropathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Diabetic Neuropathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Diabetic Neuropathy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Diabetic Neuropathy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Abbott Company Details
Table 64. Abbott Business Overview
Table 65. Abbott Diabetic Neuropathy Treatment Product
Table 66. Abbott Revenue in Diabetic Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 67. Abbott Recent Development
Table 68. Roche Company Details
Table 69. Roche Business Overview
Table 70. Roche Diabetic Neuropathy Treatment Product
Table 71. Roche Revenue in Diabetic Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 72. Roche Recent Development
Table 73. Eli Lilly Company Details
Table 74. Eli Lilly Business Overview
Table 75. Eli Lilly Diabetic Neuropathy Treatment Product
Table 76. Eli Lilly Revenue in Diabetic Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 77. Eli Lilly Recent Development
Table 78. Johnson & Johnson Company Details
Table 79. Johnson & Johnson Business Overview
Table 80. Johnson & Johnson Diabetic Neuropathy Treatment Product
Table 81. Johnson & Johnson Revenue in Diabetic Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 82. Johnson & Johnson Recent Development
Table 83. GlaxoSmithKline Company Details
Table 84. GlaxoSmithKline Business Overview
Table 85. GlaxoSmithKline Diabetic Neuropathy Treatment Product
Table 86. GlaxoSmithKline Revenue in Diabetic Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 87. GlaxoSmithKline Recent Development
Table 88. Lupin Company Details
Table 89. Lupin Business Overview
Table 90. Lupin Diabetic Neuropathy Treatment Product
Table 91. Lupin Revenue in Diabetic Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 92. Lupin Recent Development
Table 93. Glenmark Company Details
Table 94. Glenmark Business Overview
Table 95. Glenmark Diabetic Neuropathy Treatment Product
Table 96. Glenmark Revenue in Diabetic Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 97. Glenmark Recent Development
Table 98. Depomed Company Details
Table 99. Depomed Business Overview
Table 100. Depomed Revenue in Diabetic Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 101. Depomed Recent Development
Table 102. Astellas Company Details
Table 103. Astellas Business Overview
Table 104. Astellas Diabetic Neuropathy Treatment Product
Table 105. Astellas Revenue in Diabetic Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 106. Astellas Recent Development
Table 107. Pfizer Company Details
Table 108. Pfizer Business Overview
Table 109. Pfizer Diabetic Neuropathy Treatment Product
Table 110. Pfizer Revenue in Diabetic Neuropathy Treatment Business (2016-2021) & (US$ Million)
Table 111. Pfizer Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetic Neuropathy Treatment Market Share by Type: 2020 VS 2027
Figure 2. Peripheral Neuropathy Features
Figure 3. Autonomic Neuropathy Features
Figure 4. Proximal Neuropathy Features
Figure 5. Focal Neuropathy Features
Figure 6. Global Diabetic Neuropathy Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Pharmacy Case Studies
Figure 10. Diabetic Neuropathy Treatment Report Years Considered
Figure 11. Global Diabetic Neuropathy Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Diabetic Neuropathy Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Diabetic Neuropathy Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Diabetic Neuropathy Treatment Market Share by Regions (2022-2027)
Figure 15. Global Diabetic Neuropathy Treatment Market Share by Players in 2020
Figure 16. Global Top Diabetic Neuropathy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Neuropathy Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Diabetic Neuropathy Treatment Revenue in 2020
Figure 18. Global Diabetic Neuropathy Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Diabetic Neuropathy Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Diabetic Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Diabetic Neuropathy Treatment Market Share by Type (2016-2027)
Figure 22. North America Diabetic Neuropathy Treatment Market Share by Application (2016-2027)
Figure 23. North America Diabetic Neuropathy Treatment Market Share by Country (2016-2027)
Figure 24. United States Diabetic Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Diabetic Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Diabetic Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Diabetic Neuropathy Treatment Market Share by Type (2016-2027)
Figure 28. Europe Diabetic Neuropathy Treatment Market Share by Application (2016-2027)
Figure 29. Europe Diabetic Neuropathy Treatment Market Share by Country (2016-2027)
Figure 30. Germany Diabetic Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Diabetic Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Diabetic Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Diabetic Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Diabetic Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Diabetic Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Diabetic Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Diabetic Neuropathy Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Diabetic Neuropathy Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Diabetic Neuropathy Treatment Market Share by Region (2016-2027)
Figure 40. China Diabetic Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Diabetic Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Diabetic Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Diabetic Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Diabetic Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Diabetic Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Diabetic Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Diabetic Neuropathy Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Diabetic Neuropathy Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Diabetic Neuropathy Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Diabetic Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Diabetic Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Diabetic Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Diabetic Neuropathy Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Diabetic Neuropathy Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Diabetic Neuropathy Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Diabetic Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Diabetic Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Diabetic Neuropathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Abbott Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2016-2021)
Figure 60. Roche Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2016-2021)
Figure 61. Eli Lilly Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2016-2021)
Figure 64. Lupin Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2016-2021)
Figure 65. Glenmark Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2016-2021)
Figure 66. Depomed Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2016-2021)
Figure 67. Astellas Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2016-2021)
Figure 68. Pfizer Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Global Diabetic Neuropathy Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1836 2021年4月 92Pages
QYResearch社発行の本調査資料では、糖尿病性ニューロパチー治療（DN）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（末梢神経障害、自律神経障害、近位神経障害、限局性神経障害）、用途別市場規模（病院、クリニック、薬局）、主要地域別市場規...

世界の糖尿病性末梢神経障害治療市場規模・現状・予測（2021年-2027年）

Global Diabetic Peripheral Neuropathy Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1837 2021年4月 99Pages
QYResearch社発行の本調査資料では、糖尿病性末梢神経障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アンチムノセル、ASP-8477、BNV-222、カプサイシン、CBX-129801、その他）、用途別市場規模（病院、クリニック...

世界の末梢神経障害治療市場規模・現状・予測（2021年-2027年）

Global Peripheral Neuropathy Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4521 2021年4月 92Pages
QYResearch社発行の本調査資料では、末梢神経障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（カルシウムチャネルα2-デルタリガンド、抗うつ薬、オピオイド、その他）、用途別市場規模（プラチナ剤、タキサン、ビンカアルカロイド、その他...

世界の末梢神経障害治療市場規模・現状・予測（2021年-2027年）

世界の心臓自律神経障害治療市場規模・現状・予測（2021年-2027年）

Global Cardiac Autonomic Neuropathy Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1110 2021年4月 97Pages
QYResearch社発行の本調査資料では、心臓自律神経障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（固形経口、注射剤）、用途別市場規模（病院、心臓センター、外来手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界の糖尿病性胃不全麻痺治療市場規模・現状・予測（2021年-2027年）

Global Diabetic Gastroparesis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1831 2021年4月 94Pages
QYResearch社発行の本調査資料では、糖尿病性胃不全麻痺治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（医薬品、手術治療製品）、用途別市場規模（病院薬局、民間クリニック、ドラッグストア、Eコマース）、主要地域別市場規模（北米、アメリカ...

世界の化学療法誘発性末梢神経障害（CIPN）治療市場規模・現状・予測（2021年-2027年）

Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1273 2021年4月 131Pages
QYResearch社発行の本調査資料では、化学療法誘発性末梢神経障害（CIPN）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（カルシウムチャネルα2-デルタリガンド、抗うつ薬、オピオイド、その他）、用途別市場規模（プラチナ剤、タキサン、...

世界の糖尿病性胃不全麻痺治療市場規模・現状・予測（2021年-2027年）

世界の化学療法誘発性末梢神経障害（CIPN）治療市場規模・現状・予測（2021年-2027年）

世界の糖尿病黄斑浮腫治療市場規模・現状・予測（2021年-2027年）

Global Diabetic Macular Edema Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1834 2021年4月 94Pages
QYResearch社発行の本調査資料では、糖尿病黄斑浮腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（レーザー光凝固療法、薬物療法、ベバシズマブ、ラニビズマブ、トリアムシノロン）、用途別市場規模（病院、眼科クリニック、研究所、委託研究機...

世界の糖尿病性ニューロパチー治療（DN）市場規模・現状・予測（2021年-2027年） Diabetic neuropathy is a nerve damaging disorder associated with diabetes mellitus. Patients suffering from diabetes since a long time are prone to nerve damages throughout the body, as the symptoms of diabetic neuropathies cannot be diagnosed at an earlier stage. Although there is no cure for diabe…
世界の糖尿病性末梢神経障害治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Diabetic Peripheral Neuropathy Treatment Market The global Diabetic Peripheral Neuropathy Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analys…
世界の心臓自律神経障害治療市場規模・現状・予測（2021年-2027年） Cardiac Autonomic Neuropathy treatment market involves aggressively treating cardiovascular risk factors like hypertension. Cardiac autonomicdeficiency of essential fatty acids, increased oxidative stress, autoimmune damage, and formation of advanced glycosylation end products. Other therapies inclu…
世界の末梢神経障害治療市場規模・現状・予測（2021年-2027年） Peripheral neuropathy is a set of symptoms caused by any damage to the nerves that are away from the brain and spinal cord. Peripheral neuropathy is not a single, homogenous disease, but it is a mix of different clinical presentations, natural histories, and pathology. Market Analysis and Insights: …
世界の末梢神経障害治療市場規模・現状・予測（2021年-2027年） Peripheral neuropathy is a set of symptoms caused by any damage to the nerves that are away from the brain and spinal cord. Peripheral neuropathy is not a single, homogenous disease, but it is a mix of different clinical presentations, natural histories, and pathology. Market Analysis and Insights: …